Outcomes survival allogeneic stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

Stem Cells Hematopoietic Stem Cells Antilymphocyte Serum T-Lymphocytes Embryonic Stem Cells Adult Stem Cells Pluripotent Stem Cells Bone Marrow Cells Cells, Cultured Neural Stem Cells Mesenchymal Stromal Cells CD8-Positive T-Lymphocytes Bone Marrow Induced Pluripotent Stem Cells T-Lymphocytes, Cytotoxic Philadelphia Chromosome Multipotent Stem Cells CD4-Positive T-Lymphocytes Fetal Stem Cells Fetal Blood Killer Cells, Natural Lymphocytes T-Lymphocyte Subsets T-Lymphocytes, Regulatory Allografts Spermatogonia Neoplastic Stem Cells Blood Cells Plant Stems Dendritic Cells

Organisms9

Transplantation Chimera Cytomegalovirus Herpesvirus 6, Human Mice, Inbred C57BL Herpesvirus 4, Human Mice, Inbred BALB C Mice, SCID Radiation Chimera Chimera

Diseases47

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia, Myeloid, Acute Multiple Myeloma Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Myelodysplastic Syndromes Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma Hepatic Veno-Occlusive Disease Acute Disease Primary Myelofibrosis Anemia, Aplastic Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Roseolovirus Infections Leukemia, Myeloid Lymphoproliferative Disorders Hodgkin Disease Lymphoma, Non-Hodgkin Infection Opportunistic Infections Stomatitis Leukemia, Lymphocytic, Chronic, B-Cell Adenoviridae Infections Chronic Disease Lymphoma Blast Crisis Mycoses Epstein-Barr Virus Infections Lymphoma, Follicular Neoplasm Recurrence, Local Neoplasms Aspergillosis Philadelphia Chromosome Viremia Disease Progression Severe Combined Immunodeficiency Postoperative Complications Lymphoma, Mantle-Cell Disease Models, Animal Blood Group Incompatibility Iron Overload Amyloidosis Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Chemicals and Drugs50

Myeloablative Agonists Busulfan Vidarabine Immunosuppressive Agents Minor Histocompatibility Antigens Antilymphocyte Serum Melphalan Cyclophosphamide HLA Antigens Antigens, CD34 Antineoplastic Agents Antibodies, Neoplasm Cytarabine Benzamides Fusion Proteins, bcr-abl Pyrimidines Receptors, Purinergic P2X5 Piperazines Ganciclovir Granulocyte Colony-Stimulating Factor Cyclosporine Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Etoposide Benzydamine Vincristine Antigens, CD Antiviral Agents Antibodies, Monoclonal, Humanized Stem Cell Factor Viral Matrix Proteins Antigens, Viral Carmustine DNA, Viral fms-Like Tyrosine Kinase 3 Antineoplastic Agents, Alkylating Cytokines Biological Markers Thiotepa Isoantigens Thalidomide Antigens, Neoplasm Tacrolimus HLA-A2 Antigen Interferon-gamma Prednisone Methotrexate Antifungal Agents Protein Kinase Inhibitors Doxorubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Treatment Outcome Bone Marrow Transplantation Remission Induction Survival Rate Histocompatibility Testing Retrospective Studies Disease-Free Survival Lymphocyte Transfusion Survival Analysis Combined Modality Therapy Cord Blood Stem Cell Transplantation Salvage Therapy Liver Transplantation Whole-Body Irradiation Lymphocyte Depletion Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Mesenchymal Stem Cell Transplantation Prognosis Hematopoietic Stem Cell Mobilization Kidney Transplantation Cell Transplantation Immunosuppression Prospective Studies Risk Factors Fatal Outcome Heart Transplantation Immunotherapy, Adoptive Leukocyte Transfusion Transplantation, Isogeneic Flow Cytometry Lymphocyte Count Actuarial Analysis Immunotherapy Lung Transplantation Cohort Studies Kaplan-Meier Estimate Incidence Polymerase Chain Reaction Cytogenetic Analysis Clinical Trials as Topic Organ Transplantation Immunophenotyping Islets of Langerhans Transplantation Multivariate Analysis Transplantation Feasibility Studies Cell Separation Reverse Transcriptase Polymerase Chain Reaction Predictive Value of Tests Pancreas Transplantation Pilot Projects Donor Selection Leukapheresis Drug Evaluation Viral Load Transplantation, Heterologous Life Tables Lymphocyte Activation Risk Assessment Skin Transplantation Cell Culture Techniques Bone Marrow Purging Stem Cell Research Fetal Tissue Transplantation Transplantation, Heterotopic Disease Models, Animal Severity of Illness Index Case-Control Studies Cell- and Tissue-Based Therapy Lymphocyte Culture Test, Mixed Treatment Failure Immunohistochemistry Blood Component Removal Proportional Hazards Models Cell Count

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes30

Graft vs Leukemia Effect Graft vs Tumor Effect Graft Survival Virus Activation Time Factors Histocompatibility Chimerism Transplantation Immunology Immunocompromised Host Graft Rejection Cell Survival Cell Differentiation Lymphocyte Count Stem Cell Niche Cell Proliferation T-Cell Antigen Receptor Specificity Philadelphia Chromosome Hematopoiesis Cell Lineage Transplantation Tolerance Cytotoxicity, Immunologic Viral Load Regeneration Lymphocyte Activation Drug Resistance, Neoplasm Karyotype Radiation Chimera Graft vs Host Reaction Phenotype Cell Count

Disciplines and Occupations4

Hematology Outcome Assessment (Health Care)Stem Cell Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Siblings Nuclear Family Survival

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Siblings Living Donors Blood Donors Unrelated Donors

Health Care28

Treatment Outcome Survival Rate Retrospective Studies Disease-Free Survival Survival Analysis Follow-Up Studies Prospective Studies Risk Factors Fatal Outcome Actuarial Analysis Cohort Studies Kaplan-Meier Estimate Incidence Clinical Trials as Topic Multivariate Analysis Feasibility Studies Predictive Value of Tests Pilot Projects Donor Selection Outcome Assessment (Health Care)Life Tables Risk Assessment Age Factors Severity of Illness Index Case-Control Studies Treatment Failure Proportional Hazards Models Tissue and Organ Procurement

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Graft vs Host Disease Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Hematologic Neoplasms Treatment Outcome Transplantation Chimera Stem Cells Graft vs Leukemia Effect Bone Marrow Transplantation Myeloablative Agonists Tissue Donors Busulfan Remission Induction Recurrence Vidarabine Graft vs Tumor Effect Graft Survival Survival Rate Histocompatibility Testing Retrospective Studies Disease-Free Survival Lymphocyte Transfusion Survival Analysis Immunosuppressive Agents Leukemia, Myeloid, Acute Multiple Myeloma Combined Modality Therapy Leukemia Siblings Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cord Blood Stem Cell Transplantation Cytomegalovirus Infections Hematopoietic Stem Cells Salvage Therapy Minor Histocompatibility Antigens Liver Transplantation Whole-Body Irradiation Lymphocyte Depletion Myelodysplastic Syndromes Antilymphocyte Serum Neoplasm, Residual Virus Activation Time Factors Precursor Cell Lymphoblastic Leukemia-Lymphoma Histocompatibility Melphalan Chimerism Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Hepatic Veno-Occlusive Disease Cyclophosphamide Mesenchymal Stem Cell Transplantation Prognosis Cytomegalovirus Hematopoietic Stem Cell Mobilization T-Lymphocytes Acute Disease Kidney Transplantation Primary Myelofibrosis Cell Transplantation Anemia, Aplastic HLA Antigens Embryonic Stem Cells Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Antigens, CD34 Antineoplastic Agents Antibodies, Neoplasm Cytarabine Immunosuppression Transplantation Immunology Benzamides Roseolovirus Infections Adult Stem Cells Leukemia, Myeloid Immunocompromised Host Lymphoproliferative Disorders Fusion Proteins, bcr-abl Hodgkin Disease Pyrimidines Graft Rejection Cell Survival Receptors, Purinergic P2X5 Prospective Studies Nuclear Family Lymphoma, Non-Hodgkin Risk Factors Piperazines Infection Fatal Outcome Ganciclovir Granulocyte Colony-Stimulating Factor Heart Transplantation Cyclosporine Immunotherapy, Adoptive Cell Differentiation

No FAQ available that match "outcomes survival allogeneic stem cell transplantation"